PRKCA and cancer: PRKCA is mutated in a wide range of human cancers, but PRKCAD463H has not been reported in other tumors, including those more closely related to ChG (Supplementary Data 3), thus suggesting that the D463H mutation is likely to harbor a specific impact in the cell and tissue microenvironment that sustains ChG tumor initiation.